Myriad Genetics Puts Its Autoimmune Division Up for Sale
...
...
...
...
For Myriad Genetics, Foundation Medicine and other manufacturers of next-generation sequencing (NGS)-based test panels for early-stage cancer risk assessment, the recent announcement of CMS’ decision to provide limited Medicare coverage
From - National Intelligence Report
In recent months, several diagnostic companies have announced alliances with Google, and all involve…